ASAshish Sood

Ashish Sood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ashish Sood has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Kasun De Silva

    Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, The University of Sydney, Sydney, NSW, Australia

    5 shared publications
  • Saurabh Kumar

    Department of Cardiology, Westmead Hospital, Sydney, Australia

    5 shared publications
  • Ashwin Bhaskaran

    Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, The University of Sydney, Sydney, NSW, Australia

    4 shared publications
  • Allan Fowler

    Department of Radiation Oncology Liverpool Hospital Sydney New South Wales Australia

    3 shared publications
  • Ardalan Ebrahimi

    Department of Head and Neck Surgery, Liverpool Hospital, Sydney, New South Wales, Australia

    3 shared publications
  • James Wykes

    Department of Head and Neck Surgery Liverpool Hospital Sydney New South Wales Australia

    3 shared publications

Latest Publications

  • Open Access

    Prognostic value of semi-quantitative scoring systems for CCTA: A systematic review and meta-analysis

    by Gurkeerat Mann, Ashish Sood, Shaun Khanna, Rhea Machado, Joshua Kovoor, Sean Tan, Aditya Bhat, Nitesh Nerlekar, Jason Kaplan, Tej Dugal

  • Open Access

    Impact of catheter ablation for ventricular tachycardia on left ventricular ejection fraction in patients with structural heart disease

    by Ashish Sood, Samual Turnbull, Kasun De Silva, Ashwin Bhaskaran, Richard G. Bennett, Timothy G. Campbell, Liza Thomas, Saurabh Kumar

    Background: Catheter ablation (CA) is efficacious for the treatment of ventricular tachycardia (VT) in patients with structural heart disease; however, heart failure contributes to long‐term mortality in this cohort. Whether CA worsens left ventricular function requires investigation. Methods: We retrospectively analyzed 142 consecutive patients with structural heart disease undergoing CA for VT. Pre‐ablation left ventricular ejection fraction (LVEF) was compared to LVEF postablation, predictors of change in LVEF were identified, and the relationship between change in LVEF and arrhythmic recurrence was assessed. Results: Patients with ischemic cardiomyopathy (ICM) had lower pre‐ablation LVEF than patients with non‐ischemic cardiomyopathy (NICM) (36.2 ± 14.3% vs. 50.8 ± 12.8%, p < 0.001). There was no statistically significant change in LVEF following ablation for patients with ICM ( p = 0.45) or NICM ( p = 0.75). Patients with pre‐ablation LVEF ≤20% experienced the largest recovery in LVEF, mean recovery 5.3% (95% CI: 0.6–10.1), p = 0.03, with LVEF recovery postablation similar in ICM and NICM patients ( p = 0.69). Recovery of LVEF was associated with a decreased incidence of ventricular arrhythmia (VA) recurrence ( p = 0.03) and an increased VA‐recurrence‐free survival ( p = 0.04). Conclusion: CA for VT does not cause a decline in LVEF among patients with structural heart disease. The subset of patients with severely impaired LVEF may experience an increase in LVEF following ablation and an associated reduction in VA recurrence.


  • Open Access

    A critical analysis of online patient‐directed resources on catheter ablation for ventricular arrhythmias

    by Ashish Sood, Yu J. Hui, Samual Turnbull, Kasun De Silva, Ashwin Bhaskaran, Timothy G. Campbell, Richard G. Bennett, Mary S. Wong, Saurabh Kumar

    Background: Patients search online content to improve their understanding of medical procedures. The quality of online patient education materials (OPEMs) on catheter ablation of ventricular arrhythmias (VAs) requires investigation. Methods: Six predetermined search terms relating to VA ablation were used to search Google, Bing and Yahoo for written OPEMs, and YouTube for video OPEMs. Written OPEMs were assessed for readability using five readability indices to produce a required reading grade level, and quality using the DISCERN and Journal of the American Medical Association (JAMA) instruments. Video OPEMs were assessed for quality according to compliance with a list of investigator‐developed essential discussion points. Results: 1200 written and 480 videos were identified using the search strategy, of which 60 and 25 respectively were unique OPEMs included in this study. The mean reading grade level for written OPEMs was 11.3 ± 1.9, with no articles being written at the 6th grade level recommended by the American Medical Association. Using quality metrics, only 26.7% of written OPEMs attained a ‘high‐quality’ JAMA rating, and 30% had a DISCERN score of ‘good’ or better. Video OPEMs similarly had poor quality, only discussing a mean of 3.50 ± 2.57 out of 18 total essential criteria. Conclusion: There is a paucity of online patient‐directed materials on VA catheter ablation. Available OPEMs are of insufficient quality to adequately convey essential information, and written OPEMs are written at a level higher than the recommended reading level.


  • Open Access

    Emergency out-of-hours catheter ablation for ventricular arrhythmia storm: a UK and Australian experience

    by Richard G Bennett, Samual Turnbull, Ashish Sood, Myat Aung, Edward Duncan, Palash Barman, Glyn Thomas, Ashley M Nisbet, Saurabh Kumar

    There are limited data on emergency catheter ablation (CA) for ventricular arrhythmia (VA) storm. We describe the feasibility and safety of performing emergency CA in an out-of-hours setting for VA storm refractory to medical therapy at 2 tertiary hospitals. Twenty-five consecutive patients underwent out-of-hours (5pm–8am [weekday] or Friday 5pm–Monday 8am [weekend]) CA for VA storm refractory to anti-arrhythmic drugs and sedation. Baseline and procedural characteristics along with outcomes were compared to 91 consecutive patients undergoing weekday daytime-hours (8am-5pm) CA for VA storm. More patients undergoing out-of-hours CA had a left ventricular ejection fraction ≤35% (68% vs. 42%, P = 0.022), chronic kidney disease (60% vs. 20%, P < 0.001), and presented following a resuscitated out-of-hospital cardiac arrest (56% vs. 5%, P < 0.001), compared to the daytime-hours group. During median follow-up (377 [interquartile range 138-826] days), both groups experienced similar survival free from recurrent VA and VA storm. Survival free from cardiac transplant and/or mortality was lower in the out-of-hours group (44% vs. 81%, P = 0.007), but out-of-hours CA was not independently associated with increased cardiac transplant and/or mortality (hazard ratio 1.34, 95% confidence interval 0.61-2.96, P = 0.47). Of the 11 patients in the out-of-hours group who survived follow-up, VA-free survival was 91% and VA storm-free survival was 100% at 1-year after CA. Out-of-hours CA may occasionally be required to control VA storm and can be safe and efficacious in this scenario. During follow-up, cardiac transplant and/or mortality is common but undergoing out-of-hours CA was not predictive of this composite endpoint.


  • Open Access

    Remote magnetic navigation compared to contemporary manual techniques for the catheter ablation of ventricular arrhythmias in structural heart disease

    by Richard G. Bennett, Timothy Campbell, Ashish Sood, Ashwin Bhaskaran, Kasun De Silva, Lloyd Davis, Pierre Qian, Gopal Sivagangabalan, Mark J. Cooper, Clara K. Chow, et al.


  • Nodal metastasis size predicts disease‐free survival in cutaneous head and neck squamous cell carcinoma involving the parotid but not cervical nodes

    by Ashish Sood, James Wykes, John McGuinness, Allan Fowler, Ardalan Ebrahimi

    Background: The 8th edition American Joint Committee on Cancer nodal (N) staging of cutaneous squamous cell carcinoma of the head and neck (cSCCHN) is largely based on lymph node metastasis size, despite conflicting data in the literature. This study aimed to investigate the prognostic significance of largest node size in cSCCHN.Methods: Retrospective analysis of 94 patients undergoing curative‐intent treatment for nodal cSCCHN with surgery ± radiotherapy at Liverpool Hospital, Sydney, Australia was conducted. Survival outcomes were assessed using multivariate Cox regression. The primary end point was disease‐free survival (DFS). Objective measures of model performance were used in exploratory analyses to identify optimal size thresholds for predicting survival.Results: Nodal metastasis size significantly predicted DFS on multivariate analysis (hazard ratio 1.24; 95% confidence interval 1.06–1.46; P = 0.008). This prognostic impact occurred predominantly in parotid metastases (hazard ratio 1.27; 95% confidence interval 1.07–1.51; P = 0.006); each 1 cm increase in size increased the risk of recurrence or death by 27%, irrespective of the number of involved nodes. In parotid metastases, size thresholds of ≤3, 3–4.5 and >4.5 cm optimized prognostic discrimination. Extranodal extension (ENE) was associated with decreased DFS in nodes ≤3 cm in size (P = 0.025), but not in those >3 cm (P = 0.744).Conclusion: Size is an important prognostic factor in cSCCHN with parotid metastases, with optimal thresholds of ≤3, >3–4.5 and >4.5 cm. The prognostic impact of ENE was seen only in nodal metastases ≤3 cm in size. These results may have important implications for node size thresholds and inclusion of ENE in the American Joint Committee on Cancer N staging categories.


  • Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck

    by Ashish Sood, James Wykes, David Roshan, Laura Y. Wang, John McGuinness, Dion Forstner, Allan Fowler, Mark Lee, Michael Kernohan, Quan Ngo, et al.

    Background: Existing prognostic systems for metastatic cutaneous squamous cell carcinoma of the head and neck (cSCCHN) do not discriminate between the number of involved nodes beyond single versus multiple. This study aimed to determine if the number of metastatic lymph nodes is an independent prognostic factor in metastatic cSCCHN and whether it provides additional prognostic information to the American Joint Committee on Cancer (AJCC) staging.Methods: We retrospectively analysed 101 patients undergoing curative intent treatment for metastatic cSCCHN to parotid and/or neck nodes by surgery +/− radiotherapy at Liverpool Hospital, Sydney, Australia. The impact of number of nodal metastases on disease‐free survival (DFS) and risk of distant metastases was assessed using multivariate Cox regression.Results: The mean number of nodal metastases was 2.5 (range 1–12). On multivariate analysis, increasing number of nodal metastases significantly predicted reduced DFS (hazard ratio 1.17; 95% confidence interval 1.05–1.30; P = 0.004), with a 17% increased risk of recurrence or death for each additional node. This remained significant in multivariate models adjusted for AJCC 8th edition nodal and TNM stages. Number of nodal metastases was also associated with risk of distant metastatic failure (hazard ratio 1.21; 95% confidence interval 1.05–1.39; P = 0.009).Conclusion: Increasing number of nodal metastases is associated with decreased DFS and increased risk of distant metastases in metastatic cSCCHN, with a cumulative risk increase with each additional node. It provides additional prognostic information to the AJCC staging, which may be improved by incorporating information on the number of nodal metastases beyond the current single versus multiple distinction.


  • A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck

    by Ashish Sood, James Wykes, David Roshan, Laura Y. Wang, John McGuinness, Allan Fowler, Ardalan Ebrahimi

    Background: The 8th edition AJCC staging of cutaneous squamous cell carcinoma of the head and neck (cSCCHN) incorporated extranodal extension (ENE) for the first time. This study compared the prognostic performance of the 7th and 8th edition staging for cSCCHN with nodal metastases.Methods: Retrospective analysis of 96 patients with metastatic cSCCHN, comparing the ability of staging systems to predict disease‐specific and overall survival (OS) using the proportion of variation explained and Harrell's C‐index.Results: In AJCC8, the N classification was upstaged in 77% of patients due to the presence of ENE and 88% of patients were classified as TNM stage IV. AJCC8 was inferior to AJCC7 in predicting disease‐specific survival for both N and TNM stages, and OS by TNM stage.Conclusions: The majority of patients with metastatic cSCCHN have ENE and are classified as TNM stage IV based on the 8th edition staging, resulting in poor prognostic performance.